Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Breast Neoplasms × Rituximab × Clear all

Sponsor

Conditions

Lymphoma, Non-Hodgkin 6 Leukemia, Lymphocytic, Chronic, B-Cell 6 Lymphoma, Follicular 5 Lymphoma 4 Lymphoma, Mantle-Cell 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma, B-Cell 3 Lymphoma, Large B-Cell, Diffuse 2 Burkitt Lymphoma 2 Waldenstrom Macroglobulinemia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Diseases 1 Dendritic Cell Sarcoma, Interdigitating 1 Anemia 1

Interventions

Trastuzumab 6 Fulvestrant 6 Capecitabine 6 abemaciclib 5 trastuzumab deruxtecan 4 eribulin 4 Paclitaxel 4 Gemcitabine 4 sacituzumab govitecan 3 Vinorelbine 3 Docetaxel 3 Cyclophosphamide 3 selpercatinib 2 ribociclib 2 pertuzumab 2 olaparib 2 exemestane 2 Letrozole 2 Fluorouracil 2 Epirubicin 2 Doxorubicin 2 Anastrozole 2 Ado-Trastuzumab Emtansine 2 130-nm albumin-bound paclitaxel 2 tucatinib 1 talazoparib 1 palbociclib 1 neratinib 1 larotrectinib 1 inavolisib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡